O-1191
O-1191 is a synthetic cannabinoid that has been studied for its potential effects on the endocannabinoid system. It is a derivative of the classical cannabinoid structure and has been used primarily in research settings to understand the pharmacological properties of cannabinoids.
Chemical Structure[edit | edit source]
O-1191 is structurally related to other cannabinoids, featuring a core structure that interacts with the cannabinoid receptors in the body. The specific modifications in O-1191's chemical structure are designed to enhance its selectivity and potency at these receptors.
Pharmacology[edit | edit source]
O-1191 acts as a potent agonist at the CB1 and CB2 receptors, which are part of the endocannabinoid system. This system plays a crucial role in regulating various physiological processes, including pain sensation, mood, appetite, and memory.
Mechanism of Action[edit | edit source]
The mechanism of action of O-1191 involves binding to the cannabinoid receptors, which are G-protein coupled receptors. Upon binding, O-1191 activates these receptors, leading to a cascade of intracellular events that modulate neurotransmitter release and influence various physiological responses.
Therapeutic Potential[edit | edit source]
Research into O-1191 has suggested potential therapeutic applications in areas such as pain management, neuroprotection, and the treatment of certain psychiatric disorders. However, as a research chemical, it is not approved for clinical use.
Research and Development[edit | edit source]
O-1191 is primarily used in preclinical studies to explore the effects of cannabinoid receptor activation. These studies help in understanding the broader implications of cannabinoid receptor modulation and in the development of new therapeutic agents.
Safety and Toxicology[edit | edit source]
As with many research chemicals, the safety profile of O-1191 is not fully established. Studies in animal models are ongoing to determine its potential toxicological effects and to assess its safety for future therapeutic use.
Legal Status[edit | edit source]
O-1191 is classified as a research chemical and is not approved for medical use. Its legal status may vary by country, and it is typically subject to regulations governing the use of experimental compounds.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD